An Introduction to COVID-19
On 11 March 2020, the World Health Organization declared COVID-19 a global pandemic. The impact on the medical community has been huge, not only on the front line of medical care but also for those navigating patient treatment during this unprecedented situation.
The touchIMMUNOLOGY expert faculty have been sharing their experiences and advice during this challenging time through video interviews and short articles.
Corey A Siegel: SARS-CoV-2 Vaccination for Patients with IBD
We were delighted to talk to Corey Siegel (Dartmouth-Hitchcock Medical Center, Lebanon, NH, US) around the IOIBD consensus statement on SARS-CoV-2 vaccination in patients with IBD. Questions What issues were discussed at the consensus meeting of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) regarding the safety and effectiveness of SARS-CoV-2 vaccination […]
John H Stone, ACR 2020: Tocilizumab for COVID-19 Infection
It was a pleasure to be able to speak with John Stone (Massachusetts General Hospital, Boston, MA, USA) about the findings from his investigations into tocilizumab as a therapy for COVID-19 infection. His presentation entitled ‘Tocilizumab for COVID-19 Infection: A Randomized, Double-Blind, Placebo-Controlled Trial’ (Abstract Number: L07) was presented at the ACR Convergence, 5-9 November. […]
Pia Kvistborg, ESMO 2020 – The ORF1ab of SARS-CoV-2 Encodes an Immunodominant Epitope Restricted by HLA-A*01:01
touchIMMUNOLOGY meets Dr Pia Kvistborg at the Virtual 2020 ESMO Congress to discuss the presentation of her late-breaking abstract ‘The ORF1ab of SARS-CoV-2 encodes an immunodominant epitope restricted by HLA-A*01:01’ (LBA73) and initial findings from her recent study. Questions How did your collaboration with Andrea Cossarizza on SARS-CoV-2 come about? (0:12) How have you applied cancer […]
Journal articles and more to your inbox
Get the latest clinical insights from touchIMMUNOLOGYSign me up!